Last reviewed · How we verify
NCT03382990
Stent Placement and the Risk of New-onset AF in Patients With AMI
trial testing DES or BMS in Atrial Fibrillation New Onset in 40,000 participants. Status unknown.
31 December 2018
Quick facts
| Lead sponsor | Mackay Memorial Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 40,000 |
| Start date | 1 January 2018 |
| Primary completion | 31 December 2018 |
| Estimated completion | 31 December 2019 |
Drugs / interventions tested
- DES or BMS
Conditions studied
- Atrial Fibrillation New Onset — all drugs for Atrial Fibrillation New Onset →
- Acute Myocardial Infarction — all drugs for Acute Myocardial Infarction →
Sponsor
Mackay Memorial Hospital
Who can join
20 and older, any sex, with Atrial Fibrillation New Onset or Acute Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The benefit of a drug-eluting stent (DES) in patients with acute myocardial infarction (AMI) is controversial. This study will aim to observe the effect of a DES on the risk of new-onset AF in patients with AMI.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03382990
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atrial Fibrillation New Onset
Currently open trials in the same condition.
- NCT05841056 — Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial · Phase 3 · recruiting
- NCT06275503 — STROKESTOP III - Optimized Method for Atrial Fibrillation Screening · NA · recruiting
- NCT06159985 — Effect of Left Posterior Pericardiotomy for the Prevention of POAF · NA · recruiting
- NCT05444335 — Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years · NA · active not recruiting
- NCT05229211 — Tracking Atrial Fibrillation After Intensive Care Admission · recruiting
Other Mackay Memorial Hospital trials
Trials by the same sponsor.
- NCT07370285 — AI-Supported Empathy Mapping to Enhance Communication and Grit in Pediatric Nursing Students · NA · not yet recruiting
- NCT07537816 — Effects of Vadadustat on Anemia, Quality of Life, and Inflammation in Dialysis Patients · Phase 4 · not yet recruiting
- NCT07479654 — AI-Enabled Frailty Risk Prediction in Adult Congenital Heart Disease · NA · not yet recruiting
- NCT05483634 — Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause · not yet recruiting
- NCT07118267 — The Intervention of Lactobacillus Plantarum Probiotics in Adult Autistic Spectrum Disorders · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03382990 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mackay Memorial Hospital
- Last refreshed: 26 December 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03382990.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing